therascreen Solid Tumor
Trusted portfolio of solid tumor assays
Reliable detection and quantification of mutations and other cancer related genomic variants requires optimized detection kits that deliver confident results. We provide a trusted portfolio of solid tumor assays, enabling rapid and sensitive detection for your oncogene analyses. Our portfolio includes assays for both FFPE and liquid biopsy analysis.
Products
Sort
Detection
Gene analyzed
Regulatory status
17 Products found
FGFR RGQ RT-PCR Kit
For qualitative detection of alterations in the FGFR2 and FGFR3 genes
therascreen EGFR RGQ PCR Kit version 2
For sensitive detection of the most frequently occurring somatic mutations in the EGFR oncogene in less than 4 hours
therascreen PIK3CA RGQ PCR Kit (CE-IVD)
For qualitative detection of 11 mutations in the PIK3CA gene by real-time PCR
therascreen RAS Extension Pyro Kit
For quantitative detection of mutations in exons 3, and 4 of the human KRAS oncogene, and exons 2, 3, and 4 of the human NRAS oncogene
therascreen KRAS Pyro Kit
For sequencing-based detection and quantitation of cancer-related gene mutations in the KRAS gene
therascreen MGMT Pyro Kit
For quantitative measurements of methylation status in exon 1 of the human MGMT gene
therascreen BRAF Pyro Kit
For sequencing-based detection and quantitation of cancer-related gene mutations in the BRAF gene
therascreen EGFR Pyro Kit
For sequencing-based detection and quantitation of cancer-related gene mutations in the EGFR gene
therascreen BRAF RGQ PCR Kit CE
For qualitative measurement of somatic mutations in the BRAF oncogene
therascreen IDH1/2 RGQ PCR Kit CE
For the detection of 12 IDH1 and IDH2 mutations in glioma
therascreen EGFR Plasma RGQ PCR Kit
For sensitive detection of clinically proven somatic mutations in the EGFR oncogene, on cfDNA (circulating-free DNA) extracted from plasma samples
therascreen NRAS Pyro Kit
For sequencing-based detection and quantitation of cancer-related gene mutations in the NRAS gene
therascreen GIST RapidScreen Pyro Kit
For quantitative detection of mutations in the human KIT and PDGFRA genes
therascreen PITX2 RGQ PCR Kit
For clinically reliable determination of the PITX2 methylation ratio in lymph node-positive, estrogen receptor-positive and HER2-negative high-risk breast cancer patient tissue samples
therascreen UGT1A1 Pyro Kit
For genotyping of the allele variants *28 and *6 of the human UGT1A1 gene
EGFR Plus RGQ PCR Kit
For qualitative detection and identification of mutations in exons 18, 19, 20 and 21 of the EGFR gene
therascreen KRAS RGQ PCR Kit
For qualitative detection of mutations in the KRAS oncogene using real-time PCR